As of 2025-08-08, the Intrinsic Value of Indoco Remedies Ltd (INDOCO.NS) is 332.39 INR. This INDOCO.NS valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 284.05 INR, the upside of Indoco Remedies Ltd is 17.00%.
The range of the Intrinsic Value is 276.30 - 433.44 INR
Based on its market price of 284.05 INR and our intrinsic valuation, Indoco Remedies Ltd (INDOCO.NS) is undervalued by 17.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (81.87) - (68.26) | (76.85) | -127.1% |
| DCF (Growth 10y) | (64.17) - (39.25) | (54.86) | -119.3% |
| DCF (EBITDA 5y) | 276.30 - 433.44 | 332.39 | 17.0% |
| DCF (EBITDA 10y) | 213.05 - 401.83 | 282.70 | -0.5% |
| Fair Value | -304.20 - -304.20 | -304.20 | -207.09% |
| P/E | (276.21) - (262.10) | (264.04) | -193.0% |
| EV/EBITDA | 4.80 - 280.73 | 140.80 | -50.4% |
| EPV | 24.01 - 56.90 | 40.46 | -85.8% |
| DDM - Stable | (60.85) - (121.46) | (91.15) | -132.1% |
| DDM - Multi | 9.26 - 14.89 | 11.47 | -96.0% |
| Market Cap (mil) | 26,178.05 |
| Beta | 1.16 |
| Outstanding shares (mil) | 92.16 |
| Enterprise Value (mil) | 35,942.95 |
| Market risk premium | 8.31% |
| Cost of Equity | 15.51% |
| Cost of Debt | 9.65% |
| WACC | 13.86% |